You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動|大理藥業(603963.SH)再升6%此前中期淨利暴漲逾12倍
格隆匯 08-15 14:27
格隆匯8月15日丨大理藥業(603963.SH)自中報業績公佈後股價持續上漲,現漲5.95%,報13.17億元,暫成交1.64億元,最新總市值22.35億元。

(行情來源:富途證券)
日前大理藥業公佈的半年報顯示,在2019年上半年公司實現營業收入1.61億元,較上年同期下降20.74%,歸屬上市公司股東的淨利潤1223.38萬元,較上年同期增長1281.05%。
值得注意的是,今年上半年銷售費用為研發費用的70.63倍,而且2017年和2018年公司的研發人員分別僅只有9人和7人。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account